Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PMID 11146368
The risk of renal adverse reactions was increased in patients with a history of renal impairment (the weight management trials included 65 patients with a history of moderate or severe renal impairment at baseline), and occurred more frequently during dose titration
It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication
Intended Use : For laboratory research use only
Suspected neurological involvement due to B12 deficiency warrants urgent initiation of treatment and may require specialist referral
US$ 22.18
US$ 24.51
US$ 22.40
